SB
GILD icon

SIG Brokerage’s Gilead Sciences GILD Stock Holding History

SIG Brokerage’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.67M Buy
52,809
+1,506
+3% +$198K 0.13% 142
2026
Q1 		$7.15M Sell
51,303
-597
-1% -$83.6K 0.19% 102
2025
Q4 		$6.37M Sell
51,900
-178
-0.3% -$21.6K 0.2% 94
2025
Q3 		$5.78M Sell
52,078
-2,435
-4% -$277K 0.17% 113
2025
Q2 		$6.04M Buy
+54,513
New +$5.8M 0.16% 93

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SIG Brokerage's GILD Position: Q2 2026 in Review

SIG Brokerage increased its Gilead Sciences (GILD) stake by 2.9% in Q2 2026, buying an estimated $198K and bringing the position to 52,809 shares worth $6.67M. The position accounts for 0.13% of the portfolio, ranked #142.

SIG Brokerage first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.15M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SIG Brokerage held 52,809 shares of Gilead Sciences worth $6.67M as of Q2 2026.
  • SIG Brokerage bought 1,506 Gilead Sciences shares in Q2 2026, an estimated $198K.
  • Gilead Sciences made up 0.13% of SIG Brokerage's portfolio in Q2 2026, its #142 holding.
  • SIG Brokerage first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • SIG Brokerage's Gilead Sciences position peaked at $7.15M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.